BCL2 and glioblastoma: In summary, our finding showing that CFTR regulates Akt/Bcl2‐mediated anti‐apoptotic pathway, warrants future investigations into the potential of using CFTR as a therapeutic target and exploring combination therapy to target PI3K/Akt pathway in the treatment of glioblastomas.